These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1723 related articles for article (PubMed ID: 30879893)

  • 1. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Neurology Collaborators
    Lancet Neurol; 2019 May; 18(5):459-480. PubMed ID: 30879893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Neurological Disorders Collaborator Group
    Lancet Neurol; 2017 Nov; 16(11):877-897. PubMed ID: 28931491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of neurological conditions in north Africa and the Middle East, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
    GBD 2019 North Africa and the Middle East Neurology Collaborators
    Lancet Glob Health; 2024 Jun; 12(6):e960-e982. PubMed ID: 38604203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Diseases and Injuries Collaborators
    Lancet; 2024 May; 403(10440):2133-2161. PubMed ID: 38642570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Chronic Respiratory Disease Collaborators
    Lancet Respir Med; 2017 Sep; 5(9):691-706. PubMed ID: 28822787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2017 Sep; 390(10100):1211-1259. PubMed ID: 28919117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Mental Disorders Collaborators
    Lancet Psychiatry; 2022 Feb; 9(2):137-150. PubMed ID: 35026139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Diseases and Injuries Collaborators
    Lancet; 2020 Oct; 396(10258):1204-1222. PubMed ID: 33069326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017.
    Deuschl G; Beghi E; Fazekas F; Varga T; Christoforidi KA; Sipido E; Bassetti CL; Vos T; Feigin VL
    Lancet Public Health; 2020 Oct; 5(10):e551-e567. PubMed ID: 33007212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Risk Factor Collaborators
    Lancet; 2018 Nov; 392(10159):1923-1994. PubMed ID: 30496105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Dementia Collaborators
    Lancet Neurol; 2019 Jan; 18(1):88-106. PubMed ID: 30497964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study.
    ; Feigin VL; Vos T; Alahdab F; Amit AML; Bärnighausen TW; Beghi E; Beheshti M; Chavan PP; Criqui MH; Desai R; Dhamminda Dharmaratne S; Dorsey ER; Wilder Eagan A; Elgendy IY; Filip I; Giampaoli S; Giussani G; Hafezi-Nejad N; Hole MK; Ikeda T; Owens Johnson C; Kalani R; Khatab K; Khubchandani J; Kim D; Koroshetz WJ; Krishnamoorthy V; Krishnamurthi RV; Liu X; Lo WD; Logroscino G; Mensah GA; Miller TR; Mohammed S; Mokdad AH; Moradi-Lakeh M; Morrison SD; Shivamurthy VKN; Naghavi M; Nichols E; Norrving B; Odell CM; Pupillo E; Radfar A; Roth GA; Shafieesabet A; Sheikh A; Sheikhbahaei S; Shin JI; Singh JA; Steiner TJ; Stovner LJ; Wallin MT; Weiss J; Wu C; Zunt JR; Adelson JD; Murray CJL
    JAMA Neurol; 2021 Feb; 78(2):165-176. PubMed ID: 33136137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2018 Nov; 392(10159):1789-1858. PubMed ID: 30496104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Diabetes Collaborators
    Lancet; 2023 Jul; 402(10397):203-234. PubMed ID: 37356446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Forecasting Collaborators
    Lancet; 2024 May; 403(10440):2204-2256. PubMed ID: 38762325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990-2019.
    India State-Level Disease Burden Initiative Neurological Disorders Collaborators
    Lancet Glob Health; 2021 Aug; 9(8):e1129-e1144. PubMed ID: 34273302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 DALYs and HALE Collaborators
    Lancet; 2018 Nov; 392(10159):1859-1922. PubMed ID: 30415748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in health in the countries of the UK and 150 English Local Authority areas 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Steel N; Ford JA; Newton JN; Davis ACJ; Vos T; Naghavi M; Glenn S; Hughes A; Dalton AM; Stockton D; Humphreys C; Dallat M; Schmidt J; Flowers J; Fox S; Abubakar I; Aldridge RW; Baker A; Brayne C; Brugha T; Capewell S; Car J; Cooper C; Ezzati M; Fitzpatrick J; Greaves F; Hay R; Hay S; Kee F; Larson HJ; Lyons RA; Majeed A; McKee M; Rawaf S; Rutter H; Saxena S; Sheikh A; Smeeth L; Viner RM; Vollset SE; Williams HC; Wolfe C; Woolf A; Murray CJL
    Lancet; 2018 Nov; 392(10158):1647-1661. PubMed ID: 30497795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.
    ; Murray CJ; Barber RM; Foreman KJ; Abbasoglu Ozgoren A; Abd-Allah F; Abera SF; Aboyans V; Abraham JP; Abubakar I; Abu-Raddad LJ; Abu-Rmeileh NM; Achoki T; Ackerman IN; Ademi Z; Adou AK; Adsuar JC; Afshin A; Agardh EE; Alam SS; Alasfoor D; Albittar MI; Alegretti MA; Alemu ZA; Alfonso-Cristancho R; Alhabib S; Ali R; Alla F; Allebeck P; Almazroa MA; Alsharif U; Alvarez E; Alvis-Guzman N; Amare AT; Ameh EA; Amini H; Ammar W; Anderson HR; Anderson BO; Antonio CA; Anwari P; Arnlöv J; Arsic Arsenijevic VS; Artaman A; Asghar RJ; Assadi R; Atkins LS; Avila MA; Awuah B; Bachman VF; Badawi A; Bahit MC; Balakrishnan K; Banerjee A; Barker-Collo SL; Barquera S; Barregard L; Barrero LH; Basu A; Basu S; Basulaiman MO; Beardsley J; Bedi N; Beghi E; Bekele T; Bell ML; Benjet C; Bennett DA; Bensenor IM; Benzian H; Bernabé E; Bertozzi-Villa A; Beyene TJ; Bhala N; Bhalla A; Bhutta ZA; Bienhoff K; Bikbov B; Biryukov S; Blore JD; Blosser CD; Blyth FM; Bohensky MA; Bolliger IW; Bora Başara B; Bornstein NM; Bose D; Boufous S; Bourne RR; Boyers LN; Brainin M; Brayne CE; Brazinova A; Breitborde NJ; Brenner H; Briggs AD; Brooks PM; Brown JC; Brugha TS; Buchbinder R; Buckle GC; Budke CM; Bulchis A; Bulloch AG; Campos-Nonato IR; Carabin H; Carapetis JR; Cárdenas R; Carpenter DO; Caso V; Castañeda-Orjuela CA; Castro RE; Catalá-López F; Cavalleri F; Çavlin A; Chadha VK; Chang JC; Charlson FJ; Chen H; Chen W; Chiang PP; Chimed-Ochir O; Chowdhury R; Christensen H; Christophi CA; Cirillo M; Coates MM; Coffeng LE; Coggeshall MS; Colistro V; Colquhoun SM; Cooke GS; Cooper C; Cooper LT; Coppola LM; Cortinovis M; Criqui MH; Crump JA; Cuevas-Nasu L; Danawi H; Dandona L; Dandona R; Dansereau E; Dargan PI; Davey G; Davis A; Davitoiu DV; Dayama A; De Leo D; Degenhardt L; Del Pozo-Cruz B; Dellavalle RP; Deribe K; Derrett S; Des Jarlais DC; Dessalegn M; Dharmaratne SD; Dherani MK; Diaz-Torné C; Dicker D; Ding EL; Dokova K; Dorsey ER; Driscoll TR; Duan L; Duber HC; Ebel BE; Edmond KM; Elshrek YM; Endres M; Ermakov SP; Erskine HE; Eshrati B; Esteghamati A; Estep K; Faraon EJ; Farzadfar F; Fay DF; Feigin VL; Felson DT; Fereshtehnejad SM; Fernandes JG; Ferrari AJ; Fitzmaurice C; Flaxman AD; Fleming TD; Foigt N; Forouzanfar MH; Fowkes FG; Paleo UF; Franklin RC; Fürst T; Gabbe B; Gaffikin L; Gankpé FG; Geleijnse JM; Gessner BD; Gething P; Gibney KB; Giroud M; Giussani G; Gomez Dantes H; Gona P; González-Medina D; Gosselin RA; Gotay CC; Goto A; Gouda HN; Graetz N; Gugnani HC; Gupta R; Gupta R; Gutiérrez RA; Haagsma J; Hafezi-Nejad N; Hagan H; Halasa YA; Hamadeh RR; Hamavid H; Hammami M; Hancock J; Hankey GJ; Hansen GM; Hao Y; Harb HL; Haro JM; Havmoeller R; Hay SI; Hay RJ; Heredia-Pi IB; Heuton KR; Heydarpour P; Higashi H; Hijar M; Hoek HW; Hoffman HJ; Hosgood HD; Hossain M; Hotez PJ; Hoy DG; Hsairi M; Hu G; Huang C; Huang JJ; Husseini A; Huynh C; Iannarone ML; Iburg KM; Innos K; Inoue M; Islami F; Jacobsen KH; Jarvis DL; Jassal SK; Jee SH; Jeemon P; Jensen PN; Jha V; Jiang G; Jiang Y; Jonas JB; Juel K; Kan H; Karch A; Karema CK; Karimkhani C; Karthikeyan G; Kassebaum NJ; Kaul A; Kawakami N; Kazanjan K; Kemp AH; Kengne AP; Keren A; Khader YS; Khalifa SE; Khan EA; Khan G; Khang YH; Kieling C; Kim D; Kim S; Kim Y; Kinfu Y; Kinge JM; Kivipelto M; Knibbs LD; Knudsen AK; Kokubo Y; Kosen S; Krishnaswami S; Kuate Defo B; Kucuk Bicer B; Kuipers EJ; Kulkarni C; Kulkarni VS; Kumar GA; Kyu HH; Lai T; Lalloo R; Lallukka T; Lam H; Lan Q; Lansingh VC; Larsson A; Lawrynowicz AE; Leasher JL; Leigh J; Leung R; Levitz CE; Li B; Li Y; Li Y; Lim SS; Lind M; Lipshultz SE; Liu S; Liu Y; Lloyd BK; Lofgren KT; Logroscino G; Looker KJ; Lortet-Tieulent J; Lotufo PA; Lozano R; Lucas RM; Lunevicius R; Lyons RA; Ma S; Macintyre MF; Mackay MT; Majdan M; Malekzadeh R; Marcenes W; Margolis DJ; Margono C; Marzan MB; Masci JR; Mashal MT; Matzopoulos R; Mayosi BM; Mazorodze TT; Mcgill NW; Mcgrath JJ; Mckee M; Mclain A; Meaney PA; Medina C; Mehndiratta MM; Mekonnen W; Melaku YA; Meltzer M; Memish ZA; Mensah GA; Meretoja A; Mhimbira FA; Micha R; Miller TR; Mills EJ; Mitchell PB; Mock CN; Mohamed Ibrahim N; Mohammad KA; Mokdad AH; Mola GL; Monasta L; Montañez Hernandez JC; Montico M; Montine TJ; Mooney MD; Moore AR; Moradi-Lakeh M; Moran AE; Mori R; Moschandreas J; Moturi WN; Moyer ML; Mozaffarian D; Msemburi WT; Mueller UO; Mukaigawara M; Mullany EC; Murdoch ME; Murray J; Murthy KS; Naghavi M; Naheed A; Naidoo KS; Naldi L; Nand D; Nangia V; Narayan KM; Nejjari C; Neupane SP; Newton CR; Ng M; Ngalesoni FN; Nguyen G; Nisar MI; Nolte S; Norheim OF; Norman RE; Norrving B; Nyakarahuka L; Oh IH; Ohkubo T; Ohno SL; Olusanya BO; Opio JN; Ortblad K; Ortiz A; Pain AW; Pandian JD; Panelo CI; Papachristou C; Park EK; Park JH; Patten SB; Patton GC; Paul VK; Pavlin BI; Pearce N; Pereira DM; Perez-Padilla R; Perez-Ruiz F; Perico N; Pervaiz A; Pesudovs K; Peterson CB; Petzold M; Phillips MR; Phillips BK; Phillips DE; Piel FB; Plass D; Poenaru D; Polinder S; Pope D; Popova S; Poulton RG; Pourmalek F; Prabhakaran D; Prasad NM; Pullan RL; Qato DM; Quistberg DA; Rafay A; Rahimi K; Rahman SU; Raju M; Rana SM; Razavi H; Reddy KS; Refaat A; Remuzzi G; Resnikoff S; Ribeiro AL; Richardson L; Richardus JH; Roberts DA; Rojas-Rueda D; Ronfani L; Roth GA; Rothenbacher D; Rothstein DH; Rowley JT; Roy N; Ruhago GM; Saeedi MY; Saha S; Sahraian MA; Sampson UK; Sanabria JR; Sandar L; Santos IS; Satpathy M; Sawhney M; Scarborough P; Schneider IJ; Schöttker B; Schumacher AE; Schwebel DC; Scott JG; Seedat S; Sepanlou SG; Serina PT; Servan-Mori EE; Shackelford KA; Shaheen A; Shahraz S; Shamah Levy T; Shangguan S; She J; Sheikhbahaei S; Shi P; Shibuya K; Shinohara Y; Shiri R; Shishani K; Shiue I; Shrime MG; Sigfusdottir ID; Silberberg DH; Simard EP; Sindi S; Singh A; Singh JA; Singh L; Skirbekk V; Slepak EL; Sliwa K; Soneji S; Søreide K; Soshnikov S; Sposato LA; Sreeramareddy CT; Stanaway JD; Stathopoulou V; Stein DJ; Stein MB; Steiner C; Steiner TJ; Stevens A; Stewart A; Stovner LJ; Stroumpoulis K; Sunguya BF; Swaminathan S; Swaroop M; Sykes BL; Tabb KM; Takahashi K; Tandon N; Tanne D; Tanner M; Tavakkoli M; Taylor HR; Te Ao BJ; Tediosi F; Temesgen AM; Templin T; Ten Have M; Tenkorang EY; Terkawi AS; Thomson B; Thorne-Lyman AL; Thrift AG; Thurston GD; Tillmann T; Tonelli M; Topouzis F; Toyoshima H; Traebert J; Tran BX; Trillini M; Truelsen T; Tsilimbaris M; Tuzcu EM; Uchendu US; Ukwaja KN; Undurraga EA; Uzun SB; Van Brakel WH; Van De Vijver S; van Gool CH; Van Os J; Vasankari TJ; Venketasubramanian N; Violante FS; Vlassov VV; Vollset SE; Wagner GR; Wagner J; Waller SG; Wan X; Wang H; Wang J; Wang L; Warouw TS; Weichenthal S; Weiderpass E; Weintraub RG; Wenzhi W; Werdecker A; Westerman R; Whiteford HA; Wilkinson JD; Williams TN; Wolfe CD; Wolock TM; Woolf AD; Wulf S; Wurtz B; Xu G; Yan LL; Yano Y; Ye P; Yentür GK; Yip P; Yonemoto N; Yoon SJ; Younis MZ; Yu C; Zaki ME; Zhao Y; Zheng Y; Zonies D; Zou X; Salomon JA; Lopez AD; Vos T
    Lancet; 2015 Nov; 386(10009):2145-91. PubMed ID: 26321261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 87.